2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ensysce Biosciences said its first tranche of a Series C Preferred Stock financing, totaling roughly $43 million, closed on August 7, 2026, raising more than $21 million in gross proceeds. The company believes this restores compliance with Nasdaq's minimum stockholders' equity requirement and that it qualifies for a second 180-day grace period to regain compliance with the $1.00 bid price rule.
First tranche closed August 7, 2026, raising more than $21 million gross; total financing is about $43 million for 120,260 Series C Preferred shares
Second tranche depends on a clinical trial milestone that has not yet occurred
Company believes stockholders' equity is at least $2.5 million, meeting the Nasdaq Rule 5550(b)(1) requirement, pending Nasdaq confirmation
Second 180-day bid price grace period was requested from Nasdaq on August 24, 2026; Nasdaq response is pending
Jupiter Neurosciences sold 307,692 shares at $6.50 each in a registered direct offering that closed August 24, 2026, for gross proceeds of about $2.0 million before fees and expenses. The company believes the sale brings its stockholders' equity above the $2.5 million Nasdaq continued-listing requirement, but it is still waiting for Nasdaq's formal confirmation, and its shares may face delisting if compliance is not shown at its next periodic report.
Shares issued: 307,692 common shares at $6.50 each, under an agreement dated August 21, 2026
Gross proceeds: approximately $2.0 million before placement agent fees and offering expenses, closed August 24, 2026
Nasdaq stockholders' equity requirement: $2.5 million; company awaiting formal determination of compliance
Delisting risk remains if compliance is not evidenced at the next periodic report
Hormel Foods appointed Ash Bhumbla as Executive Vice President and Chief Financial Officer, effective September 8, 2026, ending Paul R. Kuehneman's service as interim CFO on that date. Mr. Bhumbla most recently served as Senior Vice President and CFO, Chicken segment, at Tyson Foods, and the filing sets out a base salary of $700,000 and sign-on awards for shareholders to weigh in the company's disclosed pay package.
Ash Bhumbla becomes Executive Vice President and Chief Financial Officer effective September 8, 2026
Paul R. Kuehneman's interim CFO role ends; he remains Vice President and Controller and Principal Accounting Officer
Bhumbla's offer includes a $700,000 base salary and an annual long-term incentive target of $2.1 million
Sign-on package includes a $700,000 cash award and restricted stock units with a $1.2 million grant date value
Hub Group received a Nasdaq notice on August 20, 2026 that it is not in compliance with Listing Rule 5250(c)(1) because it has not timely filed its quarterly report for the quarter ended June 30, 2026. The notice has no immediate effect on the listing or trading of the Class A common stock, but the company must submit an updated plan to regain compliance by August 27, 2026, and any further exception is capped at September 14, 2026.
Nasdaq notice dated August 20, 2026 cites late Form 10-Q for the quarter ended June 30, 2026 under Listing Rule 5250(c)(1)
Company must submit an updated compliance plan to Nasdaq by August 27, 2026
Delinquent 2025 Form 10-K and Q1 2026 Form 10-Q have an exception deadline of September 14, 2026
Notice has no immediate effect on listing or trading on the Nasdaq Global Select Market
Pantages Capital Acquisition Corporation received a Nasdaq notice on August 21, 2026, stating that its market value of listed securities has been below the $50 million minimum for 30 consecutive business days. Nasdaq said the notice is only a deficiency notification with no current effect on listing or trading, but the company has until February 17, 2027 to regain compliance or face a possible delisting notice.
Nasdaq notice dated August 21, 2026 cites the $50 million minimum market value of listed securities for continued listing on the Nasdaq Global Market.
The company also does not meet Nasdaq Listing Rule 5450(b)(3)(A), according to the notice.
Compliance Period runs 180 calendar days to February 17, 2027; regaining compliance requires at least $50 million for 10 consecutive business days.
The company says it is monitoring its market value and evaluating options, but gives no assurance it will regain or maintain compliance.
Oruka Therapeutics said Todd Edwards began work as its Chief Commercial Officer on August 24, 2026, under an offer letter dated July 22, 2026. Edwards previously held commercial roles at Arcutis Biotherapeutics and Incyte, and his pay package includes a $525,000 base salary, a 40% target bonus and equity grants. The appointment fills a senior commercial role, and the filing discloses the severance terms that apply if his employment ends.
Base salary of $525,000 with a discretionary bonus targeted at 40% of base salary
Stock option for 20,000 shares and RSUs for 100,000 shares, with 25% vesting on August 24, 2027
Signing bonus of $200,000, payable within 30 days of starting employment
Severance of 12 months' base salary without a change in control; 1.0 times base salary plus target bonus if termination occurs within three months before or 12 months after a change in control
Grand Canyon Education said its Chief Financial Officer, Daniel E. Bachus, was placed on paid administrative leave effective August 21, 2026, in connection with an ongoing governmental investigation involving a non-employee third party's trades in Company stock. The Company said the leave is not related to its financial statements or accounting, and that it is not a focus of the investigation. The board named Lori Browning, its Chief Accounting Officer, as interim CFO and interim principal financial officer.
Daniel E. Bachus, CFO, placed on paid administrative leave effective August 21, 2026
Lori Browning, SVP & Controller – Chief Accounting Officer, appointed interim CFO and interim principal financial officer effective August 21, 2026
Company says the leave is not due to financial statement or accounting issues and that it is not a focus of the government investigation
Company has engaged outside counsel, is conducting its own investigation and is cooperating with the government
On August 21, 2026, Skye Bioscience entered a Securities Purchase Agreement with an affiliate of Redmile Group under which the company can sell up to $22,000,000 of its common stock over three years, subject to conditions. The deal is tied to the proposed acquisition of Redx Pharma Limited and a related private placement, and the share sales would add to the number of shares outstanding.
Equity line of up to $22,000,000, reduced by any amount the funded PIPE exceeds $103,000,000; no shares are sold if the funded PIPE amount reaches $125,000,000 or more
Monthly sales capped at $2,000,000 of shares, priced at the lesser of the PIPE price and market price, with a floor 10% below the PIPE price
Warrant issued at closing to purchase shares equal to $5,000,000 divided by the PIPE price, exercisable from January 1, 2027 to January 1, 2030
Share issuances capped at 19.99% of outstanding common stock absent stockholder approval; company must file a resale registration statement within 10 business days of the closing date
At its recessed annual meeting on August 21, 2026, New Concept Energy stockholders approved issuing 2,000,000 new common shares to Realty Advisors, Inc. (RAI) for $1.00 per share in cash, or $2,000,000 in total. The issuance will proceed only after the NYSE American approves the additional listing application, and the filing states that it will cause a change in control, with RAI owning about 33.65% of outstanding shares afterward.
Stockholders approved the issuance with 1,872,051 votes for, 128,492 against and 120 abstentions.
RAI will pay $1.00 per share, $2,000,000 in total, from its working capital once the NYSE American approves the listing.
After the issuance RAI would hold 2,400,000 of 7,131,935 outstanding shares, about 33.65%, versus 400,000 shares (7.79%) it holds now.
Capricor Therapeutics said the FDA extended the PDUFA target action date for the Deramiocel Biologics License Application from August 22, 2026 to November 22, 2026, after classifying the company's amendment as a major amendment. The amendment adds 24-month open-label extension data from the Phase 3 HOPE-3 study and seeks review for a refined indication focused on upper limb function, which delays the timing of a possible FDA decision on the therapy.
PDUFA target action date moved from August 22, 2026 to November 22, 2026, a three-month extension
FDA classified the submission as a major amendment and accepted it for review through CBER
Amendment includes 24-month open-label extension data from the HOPE-3 study and a request to review a refined indication focused on upper limb function
CEO Linda Marbán said HOPE-3 met its primary endpoint, a statistically significant benefit in upper limb function
Expion Energy closed a $9.0 million private placement of 8% convertible debentures, with about $8.2 million in expected net proceeds, and acquired oil and gas assets in Eastern Louisiana for an adjusted cash price of $3,425,000. Kevin Sellers replaced Joseph Hammer as chief executive effective August 24, 2026, and the lead investor is affiliated with Hammer, who remains interim chairman. The financing is convertible into preferred stock and warrants, which could dilute shareholders, and the company is shifting into a new business line.
$9.0 million 8% convertible debentures due August 21, 2029, with net proceeds of about $8.2 million; conversion into Series A-1 preferred requires shareholder approval, with an initial conversion price of $4.25 per share.
Warrants to purchase up to 2,117,219 common shares; investors may buy up to $91.0 million of additional convertible preferred stock, subject to shareholder approval.
Acquired Eastern Louisiana oil and gas assets for an adjusted cash price of $3,425,000; the exploration agreement commits up to $4,000,000 to leasing and calls for a new lateral wellbore by February 15, 2027.
Kevin Sellers named CEO and board member effective August 24, 2026; lead purchaser Five Narrow Lane LP is affiliated with Joseph Hammer, who stepped down as CEO and remains interim chairman.
Kimbell Royalty Partners completed the $221.2 million Drop Down acquisition of mineral and royalty interests from affiliated sellers on August 21, 2026, paying about $75 million in cash and issuing 9,500,000 OpCo Common Units and an equal number of Class B Units. On August 24, 2026, it raised its guidance, with midpoint Q3 and Q4 2026 production now 10% and 15% above the midpoint of prior 2026 guidance. The new units are exchangeable into Common Units and will be covered by a resale registration statement that Kimbell must file within 5 business days of the closing.
Drop Down closed August 21, 2026: about $75 million in cash plus 9,500,000 OpCo Common Units and Class B Units (OpCo units valued at about $146.3 million)
Q3 2026 net production guidance of 26.5 to 29.5 Mboe/d; Q4 2026 guidance of 27.7 to 30.7 Mboe/d
Midpoint of guidance is 10% higher for Q3 and 15% higher for Q4 than prior 2026 guidance; cash G&A per Boe guidance lowered
Shelf registration statement to be filed within 5 business days of closing and made effective within 120 days
Azenta's President and CEO John Marotta resigned from the company and its Board effective August 22, 2026, and the Board named director Dr. Martin Madaus as interim President and CEO. The company reaffirmed its fourth quarter fiscal 2026 total revenue guidance but expects a one-time approximately $3 million consulting expense to affect fourth quarter adjusted EBITDA, and a search for a permanent CEO is underway.
John P. Marotta resigned as President, CEO and director effective August 22, 2026; the company says the resignation was not due to any disagreement on operations, policies or practices.
Dr. Martin D. Madaus, a Board member since January 2024, was elected interim President and CEO effective August 22, 2026, and will step down from the Nominating and Governance Committee chair role.
Fourth quarter fiscal 2026 total revenue guidance, issued August 4, 2026, was reaffirmed; adjusted EBITDA will be affected by a one-time approximately $3 million consulting expense.
The Board reduced its size from nine to eight members, and the company has retained Heidrick & Struggles to search for a permanent CEO.
RUM Group's affiliate signed a six-year commercial agreement with an unaffiliated U.S. cloud customer to supply GPU services at the company's Maysville, GA site, which is still under development, with a total order value of approximately $13.7 billion. In connection with the deal, the company entered a binding term sheet to issue the customer a warrant for up to 50,808,408 Class A shares at $0.01 per share, which creates potential dilution for existing shareholders, and the company disclosed that it does not currently have financing for the required spending.
Customer will buy GPU services in three tranches with a total order value of approximately $13.7 billion; the third tranche requires the customer's approval of the proposed delivery date.
Warrant covers up to 50,808,408 Class A shares at $0.01 per share; the initial 50% vests in three 16.67% tranches tied to the customer's purchases.
The remaining 50% of warrant shares can vest in five 10% tranches only if the customer signs one or more expansion agreements.
The company has no current financing for the project, and its obligations under the commercial agreement are not subject to any financing condition.
Martin Marietta completed its combination with Lhoist North America (LNA) on August 21, 2026, and issued Consideration Shares to LNA Holding as part of the deal. Under a new shareholders agreement, LNA Holding gets the right to designate one director, the board expands from ten to eleven seats, and Philipp Niemann was appointed to the new seat. The company says it will provide updated full-year 2026 revenue and Adjusted EBITDA guidance with its third-quarter results.
Combination with Lhoist North America completed on August 21, 2026; announced in a press release dated August 24, 2026
LNA Holding's stake is subject to lock-up: 50% released at the 12-month anniversary of closing and 50% at the 24-month anniversary
Philipp Niemann, CEO of Lhoist S.A., appointed to the board effective August 21, 2026 and will serve on the Finance Committee
Standstill restricts FGI and LNA Holding from acquiring shares above 12,783,660 shares (18% of common stock as of closing)
Extra Space Storage's board selected President W. Noah Springer to succeed Joseph D. Margolis as chief executive, effective January 1, 2027, when Margolis retires after serving through December 31, 2026. Margolis will then serve as an advisor to the board, and Springer will join the board on the same date.
Springer, 47, has been President since January 2026 and joined the company in 2006.
Springer's annual base salary will be $850,000, with continued eligibility for bonus and equity awards.
Margolis has served as CEO since 2017 and will remain a director until December 31, 2026.
The filing reports no financial results; the change is a leadership succession announced August 24, 2026.
Comstock Inc. closed the sale of its mineral, mining, processing and mining-district real estate entities to Mackay Precious Metals Inc., a subsidiary of Mackay Gold & Silver Corp. The company says the transaction, valued at more than $45 million, reduces ongoing costs and enhances balance sheet liquidity, and it expects a gain of about $10 million to $12 million.
Comstock has received $20 million in cash and 2 million Mackay Gold & Silver common shares, currently valued at about $4.5 million
Expected gain of about $10 million to $12 million, with no cash taxes expected on the gain
A secured second-tranche payment of $7 million is due within 18 months
Estimated annual operational savings of $1.5 million; Comstock retains a 1.5% NSR royalty and a $10 million contingent payment tied to a mine construction decision or a change-of-control deal of at least $500 million within seven years
A federal court in California ruled in several related cases involving Sable's Santa Ynez Pipeline System. The court found Sable violated the 2020 consent decree by restarting operations without state authorization, imposed a $1.449 million penalty, and declined to order a shutdown because the federal pipeline regulator PHMSA had approved the Restart Plan. The court also denied California's bid for a preliminary injunction against the federal Defense Production Act order, and California filed a notice of appeal on August 20, 2026.
Court found Sable violated the Consent Decree by restarting the onshore pipeline without OSFM authorization, but declined to order a shutdown.
Court imposed a $1.449 million penalty on the Company.
Court denied California's motion for a preliminary injunction against the DPA Order; California filed notice of appeal on August 20, 2026.
In a separate case, the court declared the DPA Order bars California Department of Parks and Recreation from suing to stop Sable's onshore operations; defendant filed notice of appeal on August 21, 2026.
Ecovyst appointed Laurie Bergman as Vice President, Chief Financial Officer and Treasurer effective August 24, 2026, replacing Michael Feehan, who had held the role since August 2021. Feehan will stay on through September 30, 2026 to transition his duties, and his separation is treated as a termination without cause with severance under his existing agreement. The change in the company's top finance role, along with the disclosed pay terms, is the key shareholder-relevant event in this filing, which contains no financial results.
Laurie Bergman, 49, becomes CFO and Treasurer effective August 24, 2026, succeeding Michael Feehan, who served in the role since August 2021.
Feehan continues as an employee of Ecovyst Catalyst Technologies LLC through September 30, 2026; his separation is considered a termination without cause.
Bergman's offer letter provides a $470,000 base salary, a target bonus of 70% of base salary, a $250,000 one-time sign-on payment and a $450,000 time-based RSU award vesting on the third anniversary of grant.
The Transition Agreement and Offer Letter will be filed as exhibits to the Form 10-Q for the quarter ending September 30, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.